Published in Br J Pharmacol on August 01, 1992
Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol (2009) 1.31
Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum (2008) 0.95
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Br J Pharmacol (1999) 0.93
Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus. Br J Pharmacol (2000) 0.82
Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand. Br J Pharmacol (2000) 0.80
Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional alpha 2-adrenoceptors. Br J Pharmacol (1996) 0.76
Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci (1983) 6.89
The kinetics of action of acetylcholine antagonists in smooth muscle. Proc R Soc Lond B Biol Sci (1966) 2.56
Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol (1985) 2.37
The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol (1989) 2.09
Potent luteolytic agents related to prostaglandin F2alpha. Nature (1974) 2.00
Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol (1986) 1.98
Estimation of agonist affinity and efficacy by direct, operational model-fitting. J Pharmacol Methods (1990) 1.67
Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Br J Pharmacol (1987) 1.61
Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors. Prostaglandins (1983) 1.40
Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists? Br J Pharmacol (1986) 1.19
How we describe competitive antagonists: three questions of usage. Trends Pharmacol Sci (1991) 1.19
Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. Prostaglandins (1983) 1.16
Relaxant potencies of prostaglandin E analogues on rabbit jugular vein. Br J Pharmacol (1989) 0.97
The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues. Br J Pharmacol (1986) 0.91
Quantitative real-time cross-sectional echocardiography in the developing normal humam fetus and newborn. Circulation (1980) 1.97
Estimation of agonist affinity and efficacy by direct, operational model-fitting. J Pharmacol Methods (1990) 1.67
The effect of stimulus mildness-broadness in the evaluation of accents. Lang Speech (1973) 1.58
Qualitative real-time cross-sectional echocardiographic imaging of the human fetus during the second half of pregnancy. Circulation (1980) 1.26
Inotropic "A" ring substituted sulmazole and isomazole analogues. J Med Chem (1990) 1.21
Inhibition of endothelium-dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence. Br J Pharmacol (1992) 1.12
Paediatric walk-out patients: characteristics and outcomes. J Paediatr Child Health (2001) 1.09
Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha. Br J Pharmacol (1999) 1.05
The benefits of using clinical pathways for managing acute paediatric illness in an emergency department. J Qual Clin Pract (2001) 0.97
Older adults' trait ratings of three age-groups around the Pacific rim. J Cross Cult Gerontol (2001) 0.93
Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br J Pharmacol (2000) 0.92
Improving asthma documentation in a paediatric emergency department. J Paediatr Child Health (1995) 0.87
Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan). Br J Pharmacol (1997) 0.87
A simple, rapid method for prenatal detection of defects in propionate metabolism. Clin Genet (1976) 0.85
College students' trait ratings of three age groups around the Pacific Rim. J Cross Cult Gerontol (1996) 0.84
Selective prostaglandin D2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats. Eur J Pharmacol (1995) 0.83
Cloning and characterisation of the rabbit 5-HT1D alpha and 5-HT1D beta receptors. FEBS Lett (1995) 0.82
Pharmacological characterisation of melatonin mt1 receptor-mediated stimulation of [35S]-GTPgammaS binding. Biochem Pharmacol (1998) 0.80
Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats. Antisense Nucleic Acid Drug Dev (1997) 0.80
Biochemical and molecular characterization of acetylcholinesterase from the hagfish Myxine glutinosa. Comp Biochem Physiol B Biochem Mol Biol (1996) 0.78
Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. Glia (1992) 0.78
The effects of a seamless model of management on the quality of care for emergency department patients. J Qual Clin Pract (2000) 0.78
Use of a dual firefly and Renilla luciferase reporter gene assay to simultaneously determine drug selectivity at human corticotrophin releasing hormone 1 and 2 receptors. Anal Biochem (2000) 0.78
Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro. BJOG (2001) 0.78
Synthesis of Hexahydrocyclopentimidazol-2-(1H)-one derivatives displaying selective DP-receptor agonist properties. Bioorg Med Chem (1996) 0.77
Cyclic-AMP-dependent Ca2+ influx elicited by prostaglandin D2 in freshly isolated nonchromaffin cells from bovine adrenal medulla. Biochim Biophys Acta (1993) 0.77
Sodium dependency of constitutive activity at 5-HT1D alpha/1D beta receptors. Ann N Y Acad Sci (1997) 0.77
Information-seeking triggered by age. Int J Aging Hum Dev (1991) 0.77
Intra-amniotic injection of thyroxine (T4Y to a human fetus. Evidence for conversion of T4 to reverse T3. Am J Obstet Gynecol (1977) 0.76
The effect of a prostaglandin DP-receptor partial agonist (192C86) on platelet aggregation and the cardiovascular system in healthy volunteers. Br J Clin Pharmacol (1992) 0.76
Detection of errors in methylmalonyl-CoA metabolism by using amniotic fluid. Clin Chem (1977) 0.75
Receptor dimerization and Hill coefficients. Trends Pharmacol Sci (1999) 0.75
Evaluation of personality content from accented speech as a function of listeners' social attitudes. Percept Mot Skills (1972) 0.75
Letter: Comments on "Speech fluency fluctuations during the menstrual cycle". J Speech Hear Res (1976) 0.75
Attribution processes and interpersonal accommodation in a bilingual setting. Lang Speech (1977) 0.75
Cardiotonic 'C' ring modified isomazole analogues. Arch Pharm (Weinheim) (1990) 0.75
Information seeking across the life span. J Soc Psychol (1988) 0.75
Development of sex-trait stereotypes among young children in the United Staes, England, and Ireland. Child Dev (1977) 0.75
Patterns of evaluation to R.P., South Welsh and Somerset accented speech. Br J Soc Clin Psychol (1971) 0.75
Antidiuretic hormone secretion: its relation to cardiac surgery and injury. J Tenn Med Assoc (1969) 0.75
Propionate metabolism in fetal livers of 15 to 19 weeks' gestation. Am J Obstet Gynecol (1975) 0.75
Medical students' descriptions of self and ideal physician. Soc Sci Med Med Psychol Med Sociol (1979) 0.75
Inotropic polyazapentalene sulmazole analogues. Arch Pharm (Weinheim) (1992) 0.75